{"id":4660,"date":"2022-10-03T00:00:14","date_gmt":"2022-10-03T00:00:14","guid":{"rendered":"https:\/\/eu.bd.com\/iv-news\/?p=4660"},"modified":"2022-08-30T08:21:49","modified_gmt":"2022-08-30T08:21:49","slug":"implementation-of-a-standardized-optimal-procedure-for-peripheral-venous-catheters-management-results-from-a-multidimensional-assessment","status":"publish","type":"post","link":"https:\/\/eu.bd.com\/iv-news\/scientific-publications\/implementation-of-a-standardized-optimal-procedure-for-peripheral-venous-catheters-management-results-from-a-multidimensional-assessment\/","title":{"rendered":"Implementation of a standardized optimal procedure for peripheral venous catheters\u2019 management: Results from a multidimensional assessment"},"content":{"rendered":"

This post is intended for\u202fa\u202fUnited Kingdom audience only<\/span>\u202f.<\/span><\/span><\/strong><\/em><\/span><\/p>\n

Right device selection and end-user training are crucial factors when developing a procedure for peripheral vascular access management (PVAM)<\/span>1<\/span><\/sup>.<\/span>\u00a0<\/span><\/p>\n

Schettini F, Ferrario L, Foglia E, et al. <\/span><\/i>The implementation of a standardized optimal procedure for peripheral venous catheters’ management: Results from a multi-dimensional assessment. PLoS One. 2022;17(1):e0263227. doi: <\/span><\/i>10.1371\/journal.pone.0263227<\/span><\/i><\/a>\u00a0<\/span><\/p>\n

Introduction<\/span><\/b>\u00a0<\/span>\u00a0<\/span><\/h4>\n

Peripheral venous catheters (PVCs) are frequently used in acute care settings<\/span>1<\/span><\/sup>. However, 35\u201350% of PVCs don\u2019t reach their intended dwell time and will need to be replaced prematurely<\/span>2<\/span><\/sup>. Catheters fail due to complications such as: phlebitis, infiltration, occlusion\/<\/span>\u00a0<\/span>mechanical failure, dislodgment or infection<\/span>2<\/span><\/sup>.\u00a0<\/span>\u00a0<\/span><\/p>\n

\u00a0<\/span>Appropriate choice of device and effective training on peripheral vascular access management (PVAM) may contribute to positive clinical outcomes<\/span>1<\/span><\/sup>.<\/span>\u00a0<\/span><\/p>\n

Methods<\/span><\/b>\u00a0<\/span><\/h4>\n

A total of 380 adult patients at two Italian hospitals were enrolled in this prospective observational study. Out of them, 68 were assigned to the standardized optimal procedure (Scenario 1), which used all three of the above BD solutions.\u00a0<\/span>\u00a0<\/span>And 312 patients were assigned to Scenario 2, where one or two of the above three solutions was used.\u00a0<\/span>\u00a0<\/span><\/p>\n

A health technology assessment (HTA) analysis was performed to assess the clinical, economic and organizational impact of using all three solutions together versus using one or two of them.<\/span>\u00a0<\/span><\/p>\n

Results<\/span><\/b>\u00a0<\/span><\/h4>\n

With the standardized optimal procedure (Scenario 1), 86.8% of cannulas were removed at the end of treatment compared with 39.4% for cannulas in Scenario 2.\u00a0<\/span>Total cost per intervention was \u20ac19.60 for Scenario 1 and \u20ac21.71 for Scenario 2. In terms of time to perform all PVAM-related activities, the standardized optimal procedure (Scenario 1) took 4.39 minutes versus 5.72 for Scenario 2.<\/span>\u00a0<\/span><\/p>\n

Conclusions<\/span><\/b>\u00a0<\/span><\/h4>\n

This study demonstrates that implementing a standardized optimal procedure may lower the incidence of complications, while reducing catheterization attempts. Longer dwell times with shorter execution times for PVC procedures have the potential to increase operational efficiency, while leading to cost savings for the healthcare facilities concerned.<\/span>\u00a0<\/span><\/p>\n

ChloraPrep<\/span><\/span>\u2122 prescribing and technical information<\/span><\/span><\/a>\u00a0<\/span><\/p>\n

Read more scientific publications<\/span><\/a><\/div>\n
\n
\n
\n \n \n\n

\u00a0<\/span>According to the literature<\/span>3\u20136<\/span><\/sup>, using <\/span>ChloraPrep<\/span>\u2122 Cutaneous Solution<\/span><\/a> before catheter insertion rapidly kills microorganisms and its antimicrobial effect can last at least 48 hours<\/span>1<\/span><\/sup>.<\/span> \u00a0<\/span>The BD Nexiva<\/span>\u2122 Closed IV Catheter System<\/span> helps prevent complications, such as phlebitis, infiltration\/extravasation, dislodgement, CRBSIs, but can also help prevent needlestick injuries<\/span>7<\/span><\/sup>.<\/span>\u00a0<\/span>Regularly flushing IV catheters with the <\/span>BD PosiFlush<\/span>\u2122 Pre-Filled Saline Syringe<\/span><\/a> may help eliminate blood reflux, maintain cannula patency, while reducing CRBSIs<\/span>1<\/span><\/sup>.<\/span>\u00a0<\/span><\/p>\n